正五聚体蛋白3与脓毒症心血管功能障碍  

Pentraxin 3 and sepsis with cardiovascular dysfunction： an up-to-date review

作　　者：康霞艳(综述) 祝益民(审校)[2] 

机构地区：[1]湖南省儿童医院南华大学儿科学院,长沙410007 [2]湖南省人民医院,长沙410005

出　　处：《中国小儿急救医学》2014年第6期390-392,共3页Chinese Pediatric Emergency Medicine

基　　金：国家十二五重大科技支撑计划（2012BAI04B01）

摘　　要：脓毒症早期并发心血管功能障碍发生率较高,早期发现、及时治疗有利于降低脓毒症病死率,其中生物学标志物起着非常重要的作用.本文就相关标志物正五聚体蛋白3与脓毒症心血管功能障碍的关系作一综述.The incidence of cardiovascular dysfunction in the early stage of sepsis is high,early detection and timely treatments are beneficial to reduce the mortality of sepsis.Biological markers are known to play a very important role in detecting and treating sepsis.The aim of this article was to review the relationship between Pentraxin 3 and sepsis with cardiovascular dysfunction.

关 键 词：正五聚体蛋白3 脓毒症 心血管功能障碍 

分 类 号：R977.1[医药卫生—药品]